SOUTH SAN FRANCISCO, Calif. – August 6, 2015 – Fluidigm Corporation (NASDAQ:FLDM) today announced its financial results for the second quarter ended June 30, 2015.   Total revenue for the second quarter of 2015 was $28.6 million, an increase of 4% from $27.6 million in the second quarter of 2014.

Developing Multi-drug Resistance Testing Kits And Equipment

Along with sample barcoding for markedly improved discovery workflows

New Callisto&#8482 System Provides an Automated Combinatorial Approach to Cell Culture

Available Free on Fluidigm's Single-Cell Community Web Portal - Script Hub&#8482

Company’s New Branding and Logo Receives Honorable Mention   SOUTH SAN FRANCISCO, Calif., June 3, 2015 – Fluidigm Corporation (NSADAQ:FLDM) announced that its Juno™ system, an advanced platform for genotyping and sample prep, was a Gold Award winner in the Industrial and Life Science Design -

Details of its new automated library preparation application for targeted sequencing

Financial results for the first quarter ended March 31, 2015

Industry Veteran to Drive Growth in Dynamic Production Genomics Market SOUTH SAN FRANCISCO, Calif.--( BUSINESS WIRE )--Fluidigm Corporation (NASDAQ:FLDM) has recruited industry veteran Steven C. McPhail to lead its new organization specifically focused on serving its production genomics customers.

PLOS ONE Paper Profiles 907 Human Cell Lines